Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 7:534:110973.
doi: 10.1016/j.jtbi.2021.110973. Epub 2021 Dec 8.

A behavioural modelling approach to assess the impact of COVID-19 vaccine hesitancy

Affiliations

A behavioural modelling approach to assess the impact of COVID-19 vaccine hesitancy

Bruno Buonomo et al. J Theor Biol. .

Abstract

We introduce a compartmental epidemic model to describe the spread of COVID-19 within a population, assuming that a vaccine is available, but vaccination is not mandatory. The model takes into account vaccine hesitancy and the refusal of vaccination by individuals, which take their decision on vaccination based on both the present and past information about the spread of the disease. Theoretical analysis and simulations show that voluntary vaccination can certainly reduce the impact of the disease but is unable to eliminate it. We also demonstrate how the information-related parameters affect the dynamics of the disease. In particular, vaccine hesitancy and refusal are better contained in case of widespread information coverage and short-term memory. Finally, the possible impact of seasonality on the spread of the disease is investigated.

Keywords: Human behaviour; Infectious disease; Seasonality; Stability; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Flow chart for the COVID-19 model (3)–(5). The population N(t) is divided into six disjoint compartments of individuals: susceptible S(t), exposed E(t), asymptomatic Ia(t), symptomatic Is(t), vaccinated V(t) and recovered R(t). Blue colour indicates the information-dependent process in the model, with M(t) ruled by (3f).
Fig. 2
Fig. 2
Dynamics in the absence of vaccination (φ0=0 days−1, D = 0). Total infectious cases (panel A) and cumulative disease-induced deaths (panel B) as predicted by model (3)–(14) (black lines) compared with Italian official data (Italian Ministry of Health, 2020b) (blue dots), in the period 16 August–13 October 2020. Initial conditions and other parameter values are given in Table 1.
Fig. 3
Fig. 3
Panel A: Contour plot of the control reproduction number RV(9) versus the information-independent constant vaccination rate, φ0, and the factor of vaccine ineffectiveness, σ. Intersection of dotted black lines indicates the value corresponding to the baseline scenario: φ0=0.002 days−1, σ = 0.2. Panel B: Plot of RV versus σ, by setting φ0=0.002 days−1 (black line) and φ0=2·10-5 days−1 (blue line). Other parameters’ values are given in Table 1.
Fig. 4
Fig. 4
VAX-0 case. Temporal dynamics of susceptible individuals S (panel A), vaccinated individuals V (panel B), symptomatic infectious individuals Is (panel C), and cumulative deaths CD (panel D), as predicted by model (3)–(14). Blue lines: constant vaccination with φ0=0.002 days−1, D = 0; black lines: information–dependent vaccination with φ0=0.002 days−1, D = 500μ/Λ; red lines: constant vaccination with φ0=φ0p1,D=0; green lines: constant vaccination with φ0=φ0p2,D=0. Initial conditions and other parameter values are given in Table 1 and Section 5.1.
Fig. 5
Fig. 5
Information-dependent vaccination case (φ0=0.002 days−1, D = 500μ/Λ). Temporal dynamics of the ratio between the information-dependent component, φ1(M), and the constant component, φ0, of the vaccination rate. Black line: VAX-0 case; blue line: VAX-30 case. Initial conditions and other parameter values are given in Table 1.
Fig. 6
Fig. 6
Impact of the information coverage, k, and the average delay, Ta=a-1, on the VAX-0 scenario as depicted by contour plots. Panel A: cumulative vaccinated individuals at the final time tf=365 days, CV(tf). Panel B: time of symptomatic prevalence peak, argmax(Is). Panel C: cumulative deaths at the final time tf=365 days, CD(tf). The intersection of dotted white lines indicates the values corresponding to the baseline scenario: k=0.8 and Ta=3 days. Initial conditions and other parameter values are given in Table 1.
Fig. 7
Fig. 7
Impact of the factor of vaccine ineffectiveness, σ, and the information-independent constant vaccination rate, φ0, on the scenario VAX-0 with constant vaccination (i.e., D=0) as illustrated by contour plots. Panel A: cumulative vaccinated individuals at the final time tf=365 days, CV(tf). Panel B: time at symptomatic prevalence peak, argmax(Is). Panel C: cumulative deaths at the final time tf=365 days, CD(tf). The intersection of dotted white lines indicates the values corresponding to the baseline scenario: σ=0.2 and φ0=0.002 days−1. Initial conditions and other parameter values are given in Table 1.
Fig. 8
Fig. 8
Impact of the factor of vaccine ineffectiveness, σ, and the information-independent constant vaccination rate, φ0, on the scenario VAX-0 with information–dependent vaccination (i.e., D=500μ/Λ), as shown by contour plots. Panel A: cumulative vaccinated individuals at the final time tf=365 days, CV(tf). Panel B: time when symptomatic prevalence peak is reached, argmax(Is). Panel C: cumulative deaths at the final time tf=365 days, CD(tf). The intersection of dotted white lines indicates the values corresponding to the baseline scenario: σ=0.2 and φ0=0.002 days−1. Initial conditions and other parameter values are given in Table 1.
Fig. 9
Fig. 9
Impact of the information coverage, k, and the transmission rate, β, on the VAX-0 scenario as shown by contour plots. Panel A: cumulative vaccinated individuals at the final time tf=365 days, CV(tf). Panel B: time of symptomatic prevalence peak, argmax(Is). Panel C: cumulative deaths at the final time tf=365 days, CD(tf). The intersection of dotted white lines indicates the values corresponding to the baseline scenario: k=0.8 and β=2.699·10-8 days−1. Initial conditions and other parameter values are given in Table 1.
Fig. 10
Fig. 10
Impact of the information delay, Ta=a-1, and the transmission rate, β, on the VAX-0 scenario as shown by contour plots. Panel A: cumulative vaccinated individuals at the final time tf=365 days, CV(tf). Panel B: time of symptomatic prevalence peak, argmax(Is). Panel C: cumulative deaths at the final time tf=365 days, CD(tf). The intersection of dotted white lines indicates the values corresponding to the baseline scenario: Ta=3 days and β=2.699·10-8 days−1. Initial conditions and other parameter values are given in Table 1.
Fig. 11
Fig. 11
Impact of the seasonality on the information–dependent vaccination case (φ0=0.002 days−1, D = 500μ/Λ). Temporal dynamics of symptomatic infectious individuals Is (panel A), and cumulative deaths CD(t) (panel B), as predicted by model (3)–(14). Blue lines: VAX-0S case (i.e., scenario including seasonality); black lines: VAX-0 case (i.e., no–seasonality scenario). Initial conditions and other parameter values are given in Table 1 and Section 6.

Similar articles

Cited by

References

    1. Audi A., AlIbrahim M., Kaddoura M., Hijazi G., Yassine H.M., Zaraket H. Seasonality of respiratory viral infections: Will COVID-19 follow suit? Frontiers in Public Health. 2020;8:576. - PMC - PubMed
    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., McGettigan J., Khetan S., Segall N., Solis J., Brosz A., Fierro C., Schwartz H., Neuzil K., Corey L., Gilbert P., Janes H., Follmann D., Marovich M., Mascola J., Polakowski L., Ledgerwood J., Graham B.S., Bennett H., Pajon R., Knightly C., Leav B., Deng W., Zhou H., Han S., Ivarsson M., Miller J., Zaks T. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine. 2021;384(5):403–416. - PMC - PubMed
    1. Bauch C.T. Imitation dynamics predict vaccinating behaviour. Proceedings of the Royal Society B: Biological Sciences. 2005;272(1573):1669–1675. - PMC - PubMed
    1. Bender J.K., Brandl M., Höhle M., Buchholz U., Zeitlmann N. Analysis of asymptomatic and presymptomatic transmission in SARS–CoV–2 outbreak, Germany, 2020. Emerging Infectious Diseases. 2021;27(4):1159. - PMC - PubMed
    1. Buckner J.H., Chowell G., Springborn M.R. Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers. Proceedings of the National Academy of Sciences. 2021;118(16):2021. - PMC - PubMed

Publication types